2nd Presentation Session

Present your company’s slides by securing a 15-minute presentation slot in front of the attending audience.

 

What is this session?

To host as many innovative companies as possible on day one, this second session opens more presenting opportunities in front of the attending audience.

 

Presentation Sessions Remaining

3.15 – Tinostamustine, a Novel Approach for the Treatment of Central Nervous System Cancers Presentation by Imbrium Therapeutics

3.30 – Improved BBB Transport via Novel AAV Capsid Engineered to Bind to TfR1 Receptor Presentation by Exegenesis Bio

3.45 – The Opportunity for Neflamapimod in Age-Related Brain Disorders Presentation by CervoMed

4.00 – Advancing NUZ-001 against ALS in the Clinic: Targeting Protein Clearance Through Adaptive Clinical Development by Neurizon

4.15 – Reimagining Levodopa Therapy with Minitablets & the OraFID Device by Navamedic

4.30 – Risvodetinib as a Potential Disease Modifying Therapy for Neurodegenerative Disease by ABLi Therapeutics 

4.45 – Presentation by Agene Bio

5.00 – Presentation by Senovia Bioscience

5.15 – Why Short Lipidated Peptidomimetics (SLiPs) Could Change the World for Patients with Chronic Pain Presentation by Mimetic Medicines